Pierre Casellas

12.4k citations

123 papers · 10.3k indexed · 3 hit papers · h-index 50

Impact in

Pharmacology top 0.05%
- Cannabis and Cannabinoid Research
Cellular and Molecular Neuroscience top 0.2%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in ⓘ

Biotechnology 24
- Transgenic Plants and Applications 21
Cellular and Molecular Neuroscience 42
- Neuroscience and Neuropharmacology Research 25
- Neuropeptides and Animal Physiology 13

Co-authors: Monsif Bouaboula (33 shared papers)Gérard Le Fur (24 shared papers)David Shire (11 shared papers)Sylvaine Galiègue (24 shared papers)Pierre Carayon (12 shared papers)Jean Marchand (7 shared papers)D. Dussossoy (12 shared papers)Dominique Carrière (9 shared papers)
Journals: Journal of Biological Chemistry (11 papers)European Journal of Biochemistry (7 papers)FEBS Letters (7 papers)Blood (7 papers)Journal of Pharmacology and Experimental Therapeutics (6 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Pierre Casellas

121 papers receiving 9.9k citations

Hit Papers

align trajectories log scale

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor 1998 · 593 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 Journal of Pharmacology and Experimental Therapeutics
1995 European Journal of Biochemistry
1993 Nature

Peers

Countries citing papers authored by Pierre Casellas

Since Specialization

Citations

This map shows the geographic impact of Pierre Casellas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Casellas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Casellas more than expected).

Fields of papers citing papers by Pierre Casellas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Casellas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Casellas. The network helps show where Pierre Casellas may publish in the future.

Co-authors

The 25 scholars most cited alongside Pierre Casellas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Casellas Line = papers co-authored together Pierre Casellas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations European Journal of Biochemistry ·Sylvaine Galiègue, Sophie Mary, Jean Marchand, D. Dussossoy, Dominique Carrière, Pierre Carayon, Monsif Bouaboula, David Shire, Gérard Le Fur, Pierre Casellas Hit paper breakdown →	1995	1416
2	lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses Nature ·A Minty, Pascale Chalon, Jean‐Marie Derocq, Xavier Dumont, Jean-Claude Guillemot, Mourad Kaghad, C. Labit, Pascal Leplatois, Philippe Liauzun, Brigitte Miloux, C. Minty, Pierre Casellas, G. Loison, Jan H. Lupker, David Shire, Pascual Ferrara, Daniel Caput Hit paper breakdown →	1993	758
3	SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor Journal of Pharmacology and Experimental Therapeutics ·M Rinaldi-Carmona, Francis Barth, J Millan, Jean‐Marie Derocq, Pierre Casellas, Christian Congy, Didier Oustric, M Sarran, Monsif Bouaboula, Bernard Calandra, M Portier, David Shire, J. C. Brelière, Gérard Le Fur Hit paper breakdown →	1998	593
4	Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochemical Journal ·Monsif Bouaboula, Caroline Poinot‐Chazel, B. Bourrié, Xavier Canat, Bernard Calandra, M Rinaldi-Carmona, G. Le Fur, Pierre Casellas	1995	444
5	A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1 Journal of Biological Chemistry ·Monsif Bouaboula, Sylvie Perrachon, Laura Milligan, Xavier Canat, Murielle Rinaldi‐Carmona, Marielle Portier, Francis Barth, Bernard Calandra, Florence Pecceu, Johannes Lupker, Jean‐Pierre Maffrand, Gérard Le Fur, Pierre Casellas	1997	396
6	Peripheral benzodiazepine receptors and mitochondrial function Neurochemistry International ·Pierre Casellas	2002	373
7	Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. Journal of Biological Chemistry ·Monsif Bouaboula, Pascale Legoux, Bernard Pessègue, B Delpech, Xavier Dumont, Marc Piechaczyk, Pierre Casellas, David Shire	1992	305
8	Cannabinoid‐receptor expression in human leukocytes European Journal of Biochemistry ·Monsif Bouaboula, Murielle L. Rinaldi, Pierre Carayon, Christine Carillon, B Delpech, David Shire, Gérard Le Fur, Pierre Casellas	1993	303
9	The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance The FASEB Journal ·Omar Jbilo, Christine Ravinet‐Trillou, M. Arnone, Isabelle Buisson, Estelle Bribes, Annick Péleraux, Géraldine Pénarier, Philippe Soubrié, Gérard Le Fur, Sylvaine Galiègue, Pierre Casellas	2005	296
10	Signaling Pathway Associated with Stimulation of CB2 Peripheral Cannabinoid Receptor European Journal of Biochemistry ·Monsif Bouaboula, Caroline Poinot‐Chazel, Jean Marchand, Xavier Canat, Bernard Bourrié, Murielle Rinaldi‐Carmona, Bernard Calandra, Gérard Le Fur, Pierre Casellas	1996	244
11	Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation European Journal of Pharmacology ·Monsif Bouaboula, Sandrine Hilairet, Jean Marchand, Lluís Fajas, Gérard Le Fur, Pierre Casellas	2005	234
12	Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells Nature ·H. Blythman, Pierre Casellas, Olivier Gros, Pierre Gros, F. K. Jansen, F Paolucci, Bernard Pau, Hubert Vidal	1981	192
13	Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores. Journal of Biological Chemistry ·Pierre Casellas, B. Bourrié, Pierre Gros, F. K. Jansen	1984	177
14	Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells Journal of Biological Chemistry ·Monsif Bouaboula, Bernard Bourrié, Murielle Rinaldi‐Carmona, David Shire, Gérard Le Fur, Pierre Casellas	1995	160
15	Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage Blood ·P Carayon, M Portier, D. Dussossoy, A. Bord, G. Petitpretre, Xavier Canat, G. Le Fur, Pierre Casellas	1996	158
16	Modulation and Functional Involvement of CB2 Peripheral Cannabinoid Receptors During B-Cell Differentiation Blood ·Pierre Carayon, Jean Marchand, D. Dussossoy, Jean‐Marie Derocq, Omar Jbilo, A. Bord, Monsif Bouaboula, Sylvaine Galiègue, Paul Mondière, Géraldine Pénarier, Gérard Le Fur, Thierry Defrance, Pierre Casellas	1998	152
17	Cannabinoids enhance human B‐cell growth at low nanomolar concentrations FEBS Letters ·Jean‐Marie Derocq, Michel Ségui, J Marchand, G. Le Fur, Pierre Casellas	1995	151
18	Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor Journal of Biological Chemistry ·Sandrine Hilairet, Monsif Bouaboula, Dominique Carrière, Gérard Le Fur, Pierre Casellas	2003	145
19	Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity Immunological Reviews ·F. K. Jansen, H. Blythman, Dominique Carrière, Pierre Casellas, Olivier Gros, Pierre Gros, J. C. Laurent, F Paolucci, Bernard Pau, Philippe Poncelet, G. Richer, Hubert Vidal, Guy A. Voisin	1982	136
20	Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells Life Sciences ·Xavier Canat, Pierre Carayon, Monsif Bouaboula, Dominique Cahard, David Shire, Claude Roque, Gérard Le Fur, Pierre Casellas	1993	117

About Pierre Casellas

Pierre Casellas is a scholar working on Biotechnology, Cellular and Molecular Neuroscience, Pharmacology, Immunology and Toxicology, having authored 123 papers that have together received 10.3k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (31 papers), Cannabis and Cannabinoid Research (30 papers), Receptor Mechanisms and Signaling (27 papers), Neuroscience and Neuropharmacology Research (25 papers), Transgenic Plants and Applications (21 papers), Pharmacological Receptor Mechanisms and Effects (14 papers), Neuropeptides and Animal Physiology (13 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). The work is most often cited by research in Pharmacology (5.0k citations), Cellular and Molecular Neuroscience (3.7k citations), Toxicology (540 citations), Endocrine and Autonomic Systems (839 citations) and Biological Psychiatry (274 citations). Pierre Casellas has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Monsif Bouaboula, Gérard Le Fur, David Shire, Sylvaine Galiègue, Pierre Carayon, Jean Marchand, D. Dussossoy, Dominique Carrière, Jean‐Marie Derocq and Bernard Calandra. Their work appears in journals such as Journal of Biological Chemistry, European Journal of Biochemistry, FEBS Letters, Blood and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact